|
WRNIP1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.002480E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.406960E-04 |
| Normal-vs-Stage2 |
1.320990E-01 |
| Normal-vs-Stage3 |
8.33159999999999E-05 |
| Normal-vs-Stage4 |
5.764100E-04 |
| Stage1-vs-Stage2 |
1.056570E-01 |
| Stage1-vs-Stage3 |
2.156800E-01 |
| Stage1-vs-Stage4 |
6.683200E-01 |
| Stage2-vs-Stage3 |
3.432400E-02 |
| Stage2-vs-Stage4 |
1.041010E-01 |
| Stage3-vs-Stage4 |
5.225000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.40379999996809E-06 |
| Normal-vs-AfricanAmerican |
2.222400E-01 |
| Normal-vs-Asian |
2.076300E-02 |
| Caucasian-vs-AfricanAmerican |
2.107400E-01 |
| Caucasian-vs-Asian |
1.307160E-01 |
| AfricanAmerican-vs-Asian |
7.055600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.424100E-04 |
| Normal-vs-Female |
2.364200E-04 |
| Male-vs-Female |
6.490800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.26879999999774E-05 |
| Normal-vs-Age(41-60Yrs) |
2.097100E-03 |
| Normal-vs-Age(61-80Yrs) |
4.607000E-04 |
| Normal-vs-Age(81-100Yrs) |
3.931200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.875800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.670400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.068000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.602200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.632000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.036800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.014100E-02 |
| Classical-VS-Follicular |
5.283400E-01 |
| Classical-VS-Other |
6.742800E-01 |
| Classical-VS-Normal |
4.377400E-04 |
| Tall-VS-Follicular |
3.710300E-02 |
| Tall-VS-Other |
5.842200E-01 |
| Tall-VS-Normal |
3.563500E-04 |
| Follicular-VS-Other |
5.986000E-01 |
| Follicular-VS-Normal |
3.562100E-02 |
| Other-VS-Normal |
1.118750E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.956100E-04 |
| Normal-vs-N1 |
1.64160000004632E-06 |
| N0-vs-N1 |
1.722290E-02 |
|
|
